Melbuj SRL
Melbuj reported total assets of 237,909 € at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Jun 2026).
The score of Melbuj shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Melbuj's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Jun 2026
- Year ended 31 Dec 2024filed on 28 Aug 2025
Melbuj's financial analysis
- Solvency4.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Melbuj
Melbuj's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1011.183.626
- VAT number
- BE1011183626
- Peppol
- Registered · 0208:1011183626 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 04 Jul 2024
- Registered office
- 1780 Wemmel
- Latest accounts
- 2025 · filed on 27 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Melbuj (SRL) has been based in Wemmel since 2024, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 20,385 € and equity of 11,472 €; its revenue is not published. Its solvency stands at 4.8%, below the median of its sector (44.2%).
Companies similar to Melbuj
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie DES Bienfaiteurs Retail sale of pharmaceutical products Schaerbeek · balance sheet 268,901 €
- Apotheek VAN Dionant Retail sale of pharmaceutical products Beersel · balance sheet 229,148 €
- LUC Thaens Retail sale of pharmaceutical products Heusden-Zolder · balance sheet 204,672 €
- Walpharma Retail sale of pharmaceutical products Arlon · balance sheet 202,753 €
- Vivapharma Retail sale of pharmaceutical products Auderghem · balance sheet 236,296 €
- I & CM Marbotin Retail sale of pharmaceutical products Schaerbeek · balance sheet 323,588 €
- Somad Retail sale of pharmaceutical products Frameries · balance sheet 170,686 €
- Curapharma Retail sale of pharmaceutical products Zaventem · balance sheet 352,271 €
Frequently asked questions about Melbuj
What is the revenue of Melbuj?
Melbuj files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Melbuj?
In Belgium, the VAT number is the company number prefixed with BE: BE1011183626 for Melbuj, if the company is VAT-registered. Its company number (CBE) is 1011.183.626.
Where is the registered office of Melbuj?
According to the CBE register, the registered office of Melbuj is in 1780 Wemmel.
What is the equity of Melbuj?
At the close of the 2025 financial year, the equity of Melbuj amounts to 11,472 €, a solvency of 4.8% of total assets.
Who manages Melbuj?
The register lists 2 active mandates at Melbuj. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Melbuj
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →